Viewing Study NCT00281827


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-02-23 @ 5:17 AM
Study NCT ID: NCT00281827
Status: TERMINATED
Last Update Posted: 2017-12-28
First Post: 2006-01-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
Sponsor: Masonic Cancer Center, University of Minnesota
Organization: